Methionine: Adisseo plans next 300'000 t/a expansion project

Bluestar Adisseo, a producer that is controlled by China's state-owned Sinochem group, is reported to plan an ~US$ 1bn investment in a 300'000 t/a Methionine production located in Quanhui Petrochemical Park, Meizhou Bay, Quanzhou, Fujian province. No details on the product specification were provided yet.

It will be constructed in two phases, with the phase 1 focusing on building process production equipment and public works, and phase 2 adding more process production equipment and storage facilities.

In September 2022, after 4 years of preparation it has officially started its ~US$ 490m phase II Nanjing plant ('BANC 2') with an additional capacity of 180'000 t/a Methionine hydroxy analog (MHA, HMTBa). The overall production capacity of Adisseo's Nanjing plant has now reached 350'000 t/a, becoming the world's largest production base in terms of scale and cost. Rhodimet® AT88 brand is a DL-Hydroxy-Methionine, containing 88% OH-Methionine.

2023/02/03